Modeling optimal cervical cancer prevention strategies in Nigeria. - Wikidata - awgldk - TriplyDB

Modeling optimal cervical cancer prevention strategies in Nigeria.

Modeling optimal cervical cancer prevention strategies in Nigeria.

http://www.wikidata.org/entity/Q33755002

about

Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective Operations research in global health: a scoping review with a focus on the themes of health equity and impact Willingness of reproductive-aged women in a Nigerian community to accept human papillomavirus vaccination for their children.Awareness, Knowledge and Attitudes Towards Cervical Cancer Amongst HIV-Positive Women Receiving Care in a Tertiary Hospital in Nigeria.Cost-effectiveness of Human Papilloma Virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage.Projected cervical Cancer incidence in Swaziland using three methods and local survey estimates.

P2860

Q28601706-F0B9DDAC-AF9D-415C-9D13-E69C10A0372C Q29994616-87164FD2-14AF-46D9-8148-7C34C6140EA4 Q39268883-6D2E32D4-594B-4F9E-8490-BE4CF91A23CC Q40212916-B1B76B69-DAFD-44E5-89E7-DEDF60CEE714 Q45323637-7F4C98D9-83E9-448C-B160-3BDEFA96BCC4 Q55438912-F7F0694B-5C83-470D-8DA7-9EB3C328A2EB

P2860

Modeling optimal cervical cancer prevention strategies in Nigeria.

http://www.wikidata.org/entity/Q33755002

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Modeling optimal cervical cancer prevention strategies in Nigeria.

@ast

Modeling optimal cervical cancer prevention strategies in Nigeria.

@en

type

label

Modeling optimal cervical cancer prevention strategies in Nigeria.

@ast

Modeling optimal cervical cancer prevention strategies in Nigeria.

@en

prefLabel

Modeling optimal cervical cancer prevention strategies in Nigeria.

@ast

Modeling optimal cervical cancer prevention strategies in Nigeria.

@en

P1433

Q33755002-9672DA64-151A-4D8E-B984-0E58838A220F

P1476

Q33755002-9E13CC21-FBA1-412B-86E3-4D147FD70BF9

P2093

Q33755002-2AAA44D7-9ED2-4ADF-A0DD-6579F53034EE

Q33755002-418675BE-F6CB-4683-BBE9-66FDBF4B6427

Q33755002-7CCA5BB6-14FB-4886-8DA6-7D9E51FB7F04

Q33755002-8A37FF80-56EB-4E9F-8F50-C3FFD58E506F

P2860

Q33755002-0D80D0B9-8F6B-4E2E-B33C-0F4E0243848F

Q33755002-17B30E74-1B4A-4DA5-8604-FBA243FCC8DE

Q33755002-19D199C8-27CC-458D-9E18-17ABDA687332

Q33755002-1B6158C9-524E-40B0-BF0C-08CAA2D2381C

Q33755002-373ED859-F3F5-4CA3-B14F-26847987D993

Q33755002-3F39C6EA-5D45-40E3-B7AE-05F1709BCDB4

Q33755002-418A8737-13D4-4E9E-8260-F3DED7A77ECE

Q33755002-41C2A8F8-AB7A-4F9D-9AC7-E99B6383E9CC

Q33755002-437F80E9-ED27-41E0-B101-15C0CA3AA78B

Q33755002-44E0E41C-C3F7-4CC2-BB9E-4C34E839B163

P2888

Q33755002-9E02F7F5-2BA4-44FC-8C71-0FA33FF78F35

P304

Q33755002-2F148690-6BE2-4419-93D0-78D429E76320

P31

Q33755002-2F57FA39-26E2-4616-AAB0-0C4FD5C59EC0

P356

Q33755002-AA8E4A55-BDFE-4427-8A8B-36EEDE283B20

P407

Q33755002-40D7DD8A-D245-482A-94AC-4E79424A5827

P478

Q33755002-7CA950E4-FF0D-43CC-A30D-F97BFE635B43

P577

Q33755002-D1056393-B7F6-4CF8-81FD-8BC4053CA06A

P5875

Q33755002-5DE31DE5-6AAA-43CC-AB42-5AB6E83EBC4E

P6179

Q33755002-8B6CF565-08E6-455C-9B34-83BBE7DD2527

P698

Q33755002-700BEF00-A623-4909-A829-2A20C97DB233

P921

Q33755002-E1542F90-2553-42C5-B8D4-D6F7349069B6

P932

Q33755002-9BC9E606-CF87-4BA1-9DC7-D52A2F954879

P356

1471-2407-14-365

P1433

P1476

Modeling optimal cervical cancer prevention strategies in Nigeria.

@en

P2093

Babatunde Akinwunmi

http://www.w3.org/2001/XMLSchema#string

Imran O Morhason-Bello

http://www.w3.org/2001/XMLSchema#string

Isaac F Adewole

http://www.w3.org/2001/XMLSchema#string

Nadia Demarteau

http://www.w3.org/2001/XMLSchema#string

P2860

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Chapter 1: HPV in the etiology of human cancer.

Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: results from a randomized study

Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study.

Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination.

Comparison of detailed and succinct cohort modelling approaches in a multi-regional evaluation of cervical cancer vaccination.

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years.

P2888

1471-2407-14-365

P304

365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-14-365

http://www.w3.org/2001/XMLSchema#string

P407

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262810045

http://www.w3.org/2001/XMLSchema#string

P6179

1018158922

http://www.w3.org/2001/XMLSchema#string

P698

24885048

http://www.w3.org/2001/XMLSchema#string

P921

P932

4057561

http://www.w3.org/2001/XMLSchema#string